To: | Eclipse MedCorp, LLC (tmdocketing@cclaw.com) |
Subject: | U.S. Trademark Application Serial No. 90615960 - ECLIPSE - GECLI.00539 |
Sent: | February 15, 2022 11:37:44 AM |
Sent As: | ecom120@uspto.gov |
Attachments: | Attachment - 1 Attachment - 2 Attachment - 3 Attachment - 4 Attachment - 5 Attachment - 6 Attachment - 7 Attachment - 8 |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 90615960
Mark: ECLIPSE
|
|
Correspondence Address:
|
|
Applicant: Eclipse MedCorp, LLC
|
|
Reference/Docket No. GECLI.00539
Correspondence Email Address: |
|
FINAL OFFICE ACTION
The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned. Respond using the Trademark Electronic Application System (TEAS) and/or Electronic System for Trademark Trials and Appeals (ESTTA). A link to the appropriate TEAS response form and/or to ESTTA for an appeal appears at the end of this Office action.
Issue date: February 15, 2022
This Office action is in response to applicant’s communication filed on January 30, 2022.
In a previous Office action dated July 31, 2021, the trademark examining attorney refused registration of the applied-for mark based on the following:
After careful consideration of applicant’s evidence and arguments, the trademark examining attorney maintains and now makes FINAL requirement in the summary of issues below. See 37 C.F.R. §2.63(b); TMEP §714.04.
SUMMARY OF ISSUES MADE FINAL THAT APPLICANT MUST ADDRESS:
IDENTIFICATION OF GOODS
Applicant must clarify the below listed wording in the identification of goods because the respective identifications are indefinite and/or too broad. See 37 C.F.R. §2.32(a)(6); TMEP §§1402.01, 1402.03.
International Class 10:
In the communication dated January 30, 2022, applicant argued against the identification required and provided screenshots of dictionary and FDA webpages as evidence that “microneedling devices” is sufficiently definite to identify its goods amongst consumers. However, applicant’s arguments are not persuasive where the evidence attached herein and applicant’s evidence from the FDA webpage clearly demonstrate that “microneedling devices” is commonly known, understood, and interpreted as a broad term that encompasses all goods of the type, namely, pens, rollers, and/or stamps. See the attached internet evidence from:
Taken together, applicant must specify the particular goods that are broadly referenced as “microneedling devices” to comport with the Trademark Act, which requires that a trademark or service mark application must include a “specification of … the goods [or services]” in connection with which the mark is being used or will be used. See 15 U.S.C. §1051(a)(2) (emphasis added), (b)(2) (emphasis added); see 15 U.S.C. §1053. Specifically, a complete application must include a “list of the particular goods or services on or in connection with which the applicant uses or intends to use the mark.” 37 C.F.R. §2.32(a)(6) (emphasis added). This requirement for a specification of the particular goods and/or services applies to applications filed under all statutory bases. See 15 U.S.C. §§1051(a)(2), 1051(b)(2), 1053, 1126(d)-(e), 1141f; 37 C.F.R. §2.32(a)(6); TMEP §§1402.01, 1402.01(b)-(c).
Applicant may respond to this issue by submitting an amended identification as suggested below, if accurate.
Suggested Amendment:
Applicant may substitute the following wording, if accurate (additions in bold):
International Class 10 microneedling devices for the treatment of skin conditions, namely, dermal pens
For assistance with identifying and classifying goods in trademark applications, please see the USPTO’s online searchable U.S. Acceptable Identification of Goods and Services Manual. See TMEP §1402.04.
PROPER RESPONSE TO FINAL OFFICE ACTION
The USPTO does not accept emails as responses to Office actions; however, emails can be used for informal communications and are included in the application record. See 37 C.F.R. §§2.62(c), 2.191; TMEP §§304.01-.02, 709.04-.05.
How to respond. Click to file a request for reconsideration of this final Office action that fully resolves all outstanding requirements and refusals and/or click to file a timely appeal to the Trademark Trial and Appeal Board (TTAB) with the required filing fee(s).
/Shari Gadson/
Shari Gadson
Trademark Examining Attorney
Law Office 120
United States Patent and Trademark Office
571-272-9319
shari.gad
RESPONSE GUIDANCE